Post-COVID cacosmia, esophageal candidiasis, and the imperative for precise diagnosis in alleviating societal impact

Coronavirus disease (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2, has lasting consequences. Post-infectious olfactory and gustatory dysfunctions (OGD), including the distressing cacosmia, persist beyond the acute phase. Global COVID-19 impact prompts focus on persistent OGD in post-recovery. Beyond physical symptoms, complications like esophageal candidiasis emerge. Recognizing the interplay between OGD and secondary conditions is vital for effective management. Societal implications, including social withdrawal and mental health challenges, highlight the need for a comprehensive approach. This background sets the stage for exploring interactions between OGD, esophageal candidiasis, and broader post-COVID recovery aspects. Early diagnosis, targeted treatment, and a holistic approach are crucial in post-COVID recovery, addressing both physical and societal challenges to ensure enhanced well-being and a smoother recovery process. This paper explores disruptions in smell and investigates the potential link between OGD and esophageal candidiasis, emphasizing the need for careful diagnostics before prescribing steroids or immunosuppressant.